Skip to main content

Closed

TRVI: Trevi Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

86thpctl

Volume

0.62×avg

Market Cap

2.59BUSD

P/E Ratio

-56.6TTM

Div Yield

-ann

Trevi Therapeutics, Inc.

TRVINASDAQ Global Market·USD·Closed

Trevi Therapeutics, Inc.

TRVINASDAQ·USD·Closed

$18.25

−0.82%

$18.25

−$0.15 (0.82%)

52W Range

86thpctl

Volume

0.62×avg

Mkt Cap

2.59BUSD

P/E

-56.6TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings